Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

9431 ARTÍCULOS , VIENDO DEL 4381 AL 4395

Clinical and metabolic response to probiotic administration in people with Parkinson's disease: A randomized, double-blind, placebo-controlled trial

Tamtaji OR, Taghizadeh M, Daneshvar Kakhaki R, Kouchaki E, Bahmani F, Borzabadi S, Oryan S, Mafi A, Asemi Z.

Clin Nutr. 2019 Jun;38(3):1031-1035. doi: 10.1016/j.clnu.2018.05.018. Epub 2018 Jun 1.

Prion-like propagation of α-synuclein in the gut-brain axis

Chen Y, Shao Q, Yuan YH, Chen NH.

Brain Res Bull. 2018 Jun;140:341-346. doi: 10.1016/j.brainresbull.2018.06.002. Epub 2018 Jun 9.

The diagnosis of progressive supranuclear palsy: current opinions and challenges

Ali F, Josephs K.

Expert Rev Neurother. 2018 Jul;18(7):603-616. doi: 10.1080/14737175.2018.1489241. Epub 2018 Jun 28.

LRRK 2 gene mutations in the pathophysiology of the ROCO domain and therapeutic targets for Parkinson's disease: a review

Chen ML, Wu RM.

J Biomed Sci. 2018 Jun 14;25(1):52. doi: 10.1186/s12929-018-0454-0.

Transdermal rotigotine patch in Parkinson's disease with a history of intestinal operation

Ogawa T, Oyama G, Hattori N.

BMJ Case Rep. 2018 Jun 15;2018:bcr2017223722. doi: 10.1136/bcr-2017-223722.

Longitudinal analysis of impulse control disorders in Parkinson disease

Corvol JC, Artaud F, Cormier-Dequaire F, Rascol O, Durif F, Derkinderen P, Marques AR, Bourdain F, Brandel JP, Pico F, Lacomblez L, Bonnet C, Brefel-Courbon C, Ory-Magne F, Grabli D, Klebe S, Mangone G, You H, Mesnage V, Lee PC, Brice A, Vidailhet M, Elbaz A; DIGPD Study Group.

Neurology. 2018 Jul 17;91(3):e189-e201. doi: 10.1212/WNL.0000000000005816. Epub 2018 Jun 20.

Sex-Related Abnormalities in Substantia Nigra Lipids in Parkinson's Disease

Seyfried TN, Choi H, Chevalier A, Hogan D, Akgoc Z, Schneider JS.

ASN Neuro. 2018 Jan-Dec;10:1759091418781889. doi: 10.1177/1759091418781889.

Now is the Critical Time for Engineered Neuroplasticity

Moritz CT.

Neurotherapeutics. 2018 Jul;15(3):628-634. doi: 10.1007/s13311-018-0637-0.

MRI-based neuroimaging: atypical parkinsonisms and other movement disorders

Kassubek J.

Curr Opin Neurol. 2018 Aug;31(4):425-430. doi: 10.1097/WCO.0000000000000578.

Noninvasive options for 'wearing-off' in Parkinson's disease: a clinical consensus from a panel of UK Parkinson's disease specialists

Fackrell R, Carroll CB, Grosset DG, Mohamed B, Reddy P, Parry M, Chaudhuri KR, Foltynie T.

Neurodegener Dis Manag. 2018 Oct;8(5):349-360. doi: 10.2217/nmt-2018-0020. Epub 2018 Jul 5.

Mirror movements and blepharoclonus as novel phenomena in hereditary diffuse leukoencephalopathy with spheroids

Traschütz A, Hattingen E, Klockgether T, Paus S.

Parkinsonism Relat Disord. 2019 Jan;58:83-84. doi: 10.1016/j.parkreldis.2018.07.001. Epub 2018 Jul 2.

Comparison of computerized methods for rapid eye movement sleep without atonia detection

Cesari M, Christensen JAE, Kempfner L, Olesen AN, Mayer G, Kesper K, Oertel WH, Sixel-Döring F, Trenkwalder C, Sorensen HBD, Jennum P.

Sleep. 2018 Oct 1;41(10). doi: 10.1093/sleep/zsy133.

Developing consensus among movement disorder specialists on clinical indicators for identification and management of advanced Parkinson's disease: a multi-country Delphi-panel approach

Antonini A, Stoessl AJ, Kleinman LS, Skalicky AM, Marshall TS, Sail KR, Onuk K, Odin PLA.

Curr Med Res Opin. 2018 Dec;34(12):2063-2073. doi: 10.1080/03007995.2018.1502165. Epub 2018 Aug 20.

Regenerative Therapies for Parkinson's Disease: An Update

Stoker TB, Barker RA.

BioDrugs. 2018 Aug;32(4):357-366. doi: 10.1007/s40259-018-0294-1.

Antipsychotic-Related Movement Disorders: Drug-Induced Parkinsonism vs. Tardive Dyskinesia-Key Differences in Pathophysiology and Clinical Management

Ward KM, Citrome L.

Neurol Ther. 2018 Dec;7(2):233-248. doi: 10.1007/s40120-018-0105-0. Epub 2018 Jul 19.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias